KATHERINE COX: Open Payments
NPI 1952858011 · BARBOURSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 26 payments from 11 companies in 2025. Trend: 2023 $991 · 2024 $607 · 2025 $491
Food & beverage: $458Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $147 |
| Amgen Inc. | 4 | $58 |
| ABBVIE INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Sage Therapeutics, LLC | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
Products named: Ozempic, TRELEGY ELLIPTA, VRAYLAR, Veozah, The Cologuard Plus Collection Kit, ZURZUVAE, OTEZLA, Rybelsus.
Industry payments across WV — which companies pay providers there.
